257 related articles for article (PubMed ID: 15836967)
1. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.
Zelman DC; Dukes E; Brandenburg N; Bostrom A; Gore M
Pain; 2005 May; 115(1-2):29-36. PubMed ID: 15836967
[TBL] [Abstract][Full Text] [Related]
2. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
[TBL] [Abstract][Full Text] [Related]
3. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy.
Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
J Vasc Nurs; 2005 Sep; 23(3):97-104. PubMed ID: 16125633
[TBL] [Abstract][Full Text] [Related]
4. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.
Gore M; Brandenburg NA; Dukes E; Hoffman DL; Tai KS; Stacey B
J Pain Symptom Manage; 2005 Oct; 30(4):374-85. PubMed ID: 16256902
[TBL] [Abstract][Full Text] [Related]
5. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.
Tölle T; Xu X; Sadosky AB
J Diabetes Complications; 2006; 20(1):26-33. PubMed ID: 16389164
[TBL] [Abstract][Full Text] [Related]
6. Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.
Vernon MK; Brandenburg NA; Alvir JM; Griesing T; Revicki DA
J Pain Symptom Manage; 2008 Jul; 36(1):54-68. PubMed ID: 18411009
[TBL] [Abstract][Full Text] [Related]
7. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East.
Hoffman DL; Sadosky A; Alvir J
Pain Pract; 2009; 9(1):35-42. PubMed ID: 19019046
[TBL] [Abstract][Full Text] [Related]
8. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints.
Paul SM; Zelman DC; Smith M; Miaskowski C
Pain; 2005 Jan; 113(1-2):37-44. PubMed ID: 15621362
[TBL] [Abstract][Full Text] [Related]
9. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.
Gore M; Brandenburg NA; Hoffman DL; Tai KS; Stacey B
J Pain; 2006 Dec; 7(12):892-900. PubMed ID: 17157775
[TBL] [Abstract][Full Text] [Related]
10. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France.
Wu EQ; Borton J; Said G; Le TK; Monz B; Rosilio M; Avoinet S
Curr Med Res Opin; 2007 Sep; 23(9):2035-42. PubMed ID: 17637204
[TBL] [Abstract][Full Text] [Related]
11. What should be the optimal cut points for mild, moderate, and severe pain?
Li KK; Harris K; Hadi S; Chow E
J Palliat Med; 2007 Dec; 10(6):1338-46. PubMed ID: 18095813
[TBL] [Abstract][Full Text] [Related]
12. The burden of neuropathic pain: results from a cross-sectional survey.
McDermott AM; Toelle TR; Rowbotham DJ; Schaefer CP; Dukes EM
Eur J Pain; 2006 Feb; 10(2):127-35. PubMed ID: 16310716
[TBL] [Abstract][Full Text] [Related]
13. Sleep impairment in patients with painful diabetic peripheral neuropathy.
Zelman DC; Brandenburg NA; Gore M
Clin J Pain; 2006 Oct; 22(8):681-5. PubMed ID: 16988563
[TBL] [Abstract][Full Text] [Related]
14. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
Bastyr EJ; Price KL; Bril V;
Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
16. The exploration of the establishment of cutpoints to categorize the severity of acute postoperative pain.
Dihle A; Helseth S; Paul SM; Miaskowski C
Clin J Pain; 2006 Sep; 22(7):617-24. PubMed ID: 16926577
[TBL] [Abstract][Full Text] [Related]
17. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?
Hoffman DL; Sadosky A; Dukes EM; Alvir J
Pain; 2010 May; 149(2):194-201. PubMed ID: 20303665
[TBL] [Abstract][Full Text] [Related]
18. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
[TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy.
Sadosky A; Mardekian J; Parsons B; Hopps M; Bienen EJ; Markman J
J Diabetes Complications; 2015 Mar; 29(2):212-7. PubMed ID: 25498300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
